Camille L Bedrosian - Net Worth and Insider Trading

Camille L Bedrosian Net Worth

The estimated net worth of Camille L Bedrosian is at least $2 Million dollars as of 2024-05-15. Camille L Bedrosian is the EVP and Chief Medical Officer of Ultragenyx Pharmaceutical Inc and owns about 46,720 shares of Ultragenyx Pharmaceutical Inc (RARE) stock worth over $2 Million. Details can be seen in Camille L Bedrosian's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Camille L Bedrosian has not made any transactions after 2023-03-01 and currently still holds the listed stock(s).

Transaction Summary of Camille L Bedrosian

To

Camille L Bedrosian Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Camille L Bedrosian owns 4 companies in total, including Ultragenyx Pharmaceutical Inc (RARE) , Crinetics Pharmaceuticals Inc (CRNX) , and ARIAD Pharmaceuticals Inc (ARIA) among others .

Click here to see the complete history of Camille L Bedrosian’s form 4 insider trades.

Insider Ownership Summary of Camille L Bedrosian

Ticker Comapny Transaction Date Type of Owner
RARE Ultragenyx Pharmaceutical Inc 2023-03-01 EVP and Chief Medical Officer
CRNX Crinetics Pharmaceuticals Inc 2020-09-01 director
ARIA ARIAD Pharmaceuticals Inc 2007-04-16 VP & Chief Medical Officer
2020-12-09 director

Camille L Bedrosian Latest Holdings Summary

Camille L Bedrosian currently owns a total of 1 stock. Camille L Bedrosian owns 46,720 shares of Ultragenyx Pharmaceutical Inc (RARE) as of March 1, 2023, with a value of $2 Million.

Latest Holdings of Camille L Bedrosian

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
RARE Ultragenyx Pharmaceutical Inc 2023-03-01 46,720 40.97 1,914,118

Holding Weightings of Camille L Bedrosian


Camille L Bedrosian Form 4 Trading Tracker

According to the SEC Form 4 filings, Camille L Bedrosian has made a total of 11 transactions in Ultragenyx Pharmaceutical Inc (RARE) over the past 5 years, including 0 buys and 11 sells. The most-recent trade in Ultragenyx Pharmaceutical Inc is the sale of 3,881 shares on March 1, 2023, which brought Camille L Bedrosian around $175,615.

Insider Trading History of Camille L Bedrosian

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Camille L Bedrosian Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Camille L Bedrosian Ownership Network

Ownership Network List of Camille L Bedrosian

No Data

Ownership Network Relation of Camille L Bedrosian


Camille L Bedrosian Owned Company Details

What does Ultragenyx Pharmaceutical Inc do?

Who are the key executives at Ultragenyx Pharmaceutical Inc?

Camille L Bedrosian is the EVP and Chief Medical Officer of Ultragenyx Pharmaceutical Inc. Other key executives at Ultragenyx Pharmaceutical Inc include EVP and Chief Medical Officer Eric Crombez , CBO & Senior Vice President Thomas Richard Kassberg , and EVP and General Counsel Karah Herdman Parschauer .

Ultragenyx Pharmaceutical Inc (RARE) Insider Trades Summary

Over the past 18 months, Camille L Bedrosian made 1 insider transaction in Ultragenyx Pharmaceutical Inc (RARE) with a net sale of 3,881. Other recent insider transactions involving Ultragenyx Pharmaceutical Inc (RARE) include a net sale of 5,605 shares made by Theodore Alan Huizenga , a net sale of 127,435 shares made by Emil D Kakkis , and a net sale of 54,366 shares made by Thomas Richard Kassberg .

In summary, during the past 3 months, insiders sold 39,487 shares of Ultragenyx Pharmaceutical Inc (RARE) in total and bought 0 shares, with a net sale of 39,487 shares. During the past 18 months, 243,647 shares of Ultragenyx Pharmaceutical Inc (RARE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 243,647 shares.

Ultragenyx Pharmaceutical Inc (RARE)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Ultragenyx Pharmaceutical Inc Insider Transactions

No Available Data

Camille L Bedrosian Mailing Address

Above is the net worth, insider trading, and ownership report for Camille L Bedrosian. You might contact Camille L Bedrosian via mailing address: C/o Ultragenyx Pharmaceutical Inc., 60 Leveroni Court, Novato Ca 94949.

Discussions on Camille L Bedrosian

No discussions yet.